Write For Us

Obesity drug maker Novo Nordisk lifts outlook again | REUTERS

Sponsored Post Vitamin D2 Canada Persia
7 Views
Published
Novo Nordisk raised its 2024 outlook and delivered better-than-expected first-quarter profits as the Danish drugmaker races to boost output of its Wegovy weight-loss drug and fend off competition from rival Eli Lilly.

#News #novonordisk #wegovy #earnings #health #Reuters #Newsfeed

Read the story here: https://reut.rs/3xUzPEw

???? Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, news, world news today
Sign in or sign up to post comments.
Be the first to comment